Overview of ALK and ROS1 Rearranged Lung Cancer / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 236-237, 2013.
Article
in English
| WPRIM
| ID: wpr-194722
ABSTRACT
Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic process of non-small cell lung cancer. This study aims to investigate anplastic lymphoma kinase, c-ros oncogene 1, and receptor tyrosine kinase, in particular.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Oncogenes
/
Phosphotransferases
/
Protein-Tyrosine Kinases
/
Gene Rearrangement
/
Carcinoma, Non-Small-Cell Lung
/
Carcinogenesis
/
ErbB Receptors
/
Lung
/
Lung Neoplasms
/
Lymphoma
Language:
English
Journal:
Tuberculosis and Respiratory Diseases
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS